Psyched Wellness Secures Funding and Expertise for AME-1 Products
Company Announcements

Psyched Wellness Secures Funding and Expertise for AME-1 Products

Psyched Wellness Ltd (TSE:PSYC) has released an update.

Psyched Wellness Ltd. has successfully closed a US$2.5 million funding round with Gotham Green Partners, culminating in a total of US$7.5 million raised. The company is partnering with strategic advisors from Zerkalo, LLC to develop and market a new consumer packaged goods product derived from the AME-1 strain of the Amanita Muscaria mushroom. This collaboration aims to leverage the advisors’ past success with Harmless Harvest and their expertise in building environmentally conscious and innovative consumer brands.

For further insights into TSE:PSYC stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskPsyched Wellness Grows Retail Network and Appoints New CFO
TipRanks Canadian Auto-Generated NewsdeskPsyched Wellness Unveils Legal Mushroom Gummies
TipRanks Canadian Auto-Generated NewsdeskPsyched Wellness Completes Major Funding Round
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Optimize your mobile reading experience. Download the TipRanks App today!